A Cell-Autonomous Signature of Dysregulated Protein Phosphorylation Underlies Muscle Insulin Resistance in Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Summary Skeletal muscle insulin resistance is the earliest defect in type 2 diabetes (T2D), preceding and predicting disease development. To what extent this reflects a primary defect or is secondary to tissue crosstalk due to changes in hormones or circulating metabolites is unknown. To address this question, we have developed an in vitro disease-in-a-dish model using iPS cells from T2D patients differentiated into myoblasts (iMyo). We find that T2D iMyos in culture exhibit multiple defects mirroring human disease, including altered insulin signaling, decreased insulin-stimulated glucose uptake, and reduced mitochondrial oxidation. More striking, global phosphoproteomic analysis reveals a multi-dimensional network of signaling defects in T2D iMyos going beyond the canonical insulin signaling cascade and including proteins involved in regulation of Rho-GTPases, mRNA splicing/processing, vesicular trafficking, gene transcription and chromatin-remodeling. These cell-autonomous defects and dysregulated network of protein phosphorylation reveal a new dimension in the cellular mechanisms underlying the fundamental defects in T2D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Szklarczyk, D., Gable, A. L., Lyon, D., Junge, A., Wyder, S., Huerta-Cepas, J., Simonovic, M., Doncheva, N. T., Morris, J. H., Bork, P., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1131 · Cited by 17,749 · cited 1×
“Pathway and ontology analysis of protein clusters was done using STRING database (Szklarczyk et al., 2019).”
MethodAKT/PKB Signaling: Navigating the Network
Manning, B. D., & Toker, A. (2017) · Cell · doi:10.1016/j.cell.2017.04.001 · Cited by 3,772 · cited 1×
“Activation of mTORC1 results from a complex interplay between GTP-loading of RHEB, as a result of inhibition of TSC2 GAP activity by AKT (Manning and Toker, 2017), and relief of inhibitory activity on RAPTOR through AKT-mediated phosphorylation of PRAS40T246 (Sancak et al.”
BackgroundMechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028 · cited 3×
“, 1996), and impaired insulinstimulated glucose transport, glycolytic flux, glycogen synthesis and mitochondrial ATP production (Cline et al., 1999; Petersen and Shulman, 2018; Stump et al., 2003).”
BackgroundInflammatory mechanisms linking obesity and metabolic disease
Saltiel, A. R., & Olefsky, J. M. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92035 · Cited by 2,212 · cited 1×
“Multiple studies have shown that a variety of circulating factors, including increased levels of free fatty acids, ceramides, cytokines and other inflammatory mediators, as well as altered levels of branched chain amino acids and other metabolites may be increased in serum of T2D patients and contribute to the insulin…”
BackgroundSkeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
DeFronzo, R. A., & Tripathy, D. (2009) · Diabetes Care · doi:10.2337/dc09-s302 · Cited by 2,102 · cited 1×
“, 1990), which is of critical relevance since this tissue is the primary site of glucose disposal when insulin levels are high as in the post-prandial state or during an euglycemic-hyperinsulinemic clamp (DeFronzo and Tripathy, 2009; Kowalski and Bruce, 2014).”
BackgroundPatti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952
Self-citationInduced pluripotent stem cell technology: a decade of progress.
Shi, Y., Inoue, H., Wu, J. C., & Yamanaka, S. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.245 · Cited by 1,525 · cited 1×
“Induced pluripotent stem cells (iPSCs) have unlimited expansion potential and their ability to be differentiated in vitro provides a unique opportunity to study and model human disease (Shi et al., 2017).”
BackgroundPRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase
Sancak, Y., Thoreen, C. C., Peterson, T. R., Lindquist, R. A., Kang, S. A., Spooner, E., Carr, S. A., & Sabatini, D. M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.03.003 · Cited by 1,236 · cited 2×
“Activation of mTORC1 results from a complex interplay between GTP-loading of RHEB, as a result of inhibition of TSC2 GAP activity by AKT (Manning and Toker, 2017), and relief of inhibitory activity on RAPTOR through AKT-mediated phosphorylation of PRAS40T246 (Sancak et al., 2007).”
BackgroundMartin, B. C., Warram, J. H., Krolewski, A. S., Soeldner, J. S., Kahn, C. R., Martin, B. C., & Bergman, R. N. (1992) · The Lancet · doi:10.1016/0140-6736(92)92814-v · Cited by 1,158 · cited 1×
“Indeed, offspring of type 2 diabetic parents who are at high risk for developing T2D exhibit insulin resistance many years before diagnosis, and this predicts development of T2D in these individuals (Martin et al., 1992).”
BackgroundSelf-citationCusi, K., Maezono, K., Osman, A., Pendergrass, M., Patti, M. E., Pratipanawatr, T., DeFronzo, R. A., Kahn, C. R., & Mandarino, L. J. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7535 · Cited by 1,139 · cited 1×
“These include altered insulin-stimulated IRS protein phosphorylation and PI-kinase activation (Cusi et al., 2000), reduced expression of mitochondrial genes (Mootha et al.”
BackgroundSelf-citationHsu, P. P., Kang, S. A., Rameseder, J., Zhang, Y., Ottina, K. A., Lim, D., Peterson, T. R., Choi, Y., Gray, N. S., Yaffe, M. B., et al. (2011) · Science · doi:10.1126/science.1199498 · Cited by 1,084
Interplay between lipids and branched-chain amino acids in development of insulin resistance
Newgard, C. B. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.01.024 · Cited by 1,080 · cited 2×
“Multiple studies have shown that a variety of circulating factors, including increased levels of free fatty acids, ceramides, cytokines and other inflammatory mediators, as well as altered levels of branched chain amino acids and other metabolites may be increased in serum of T2D patients and contribute to the insulin…”
BackgroundWarram, J. H., Martin, B. C., Krolewski, A. S., Soeldner, J. S., & Kahn, C. R. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-12-909 · Cited by 1,038
Self-citationCopps, K. D., & White, M. F. (2012) · Diabetologia · doi:10.1007/s00125-012-2644-8 · Cited by 1,017 · cited 1×
“Dysregulated serine phosphorylation of IRS-1 and IRS-2 represents a key mechanism to promote insulin resistance by interference of IRS-1/2 tyrosine phosphorylation and/or increased proteolytic degradation (Copps and White, 2012).”
BackgroundCline, G. W., Petersen, K. F., Krssak, M., Shen, J., Hundal, R. S., Trajanoski, Z., Inzucchi, S., Dresner, A., Rothman, D. L., & Shulman, G. I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907223410404 · Cited by 675
Samuel, V. T., Liu, Z.-X., Wang, A., Beddow, S. A., Geisler, J. G., Kahn, M., Zhang, X.-M., Monia, B. P., Bhanot, S., & Shulman, G. I. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30400 · Cited by 497 · cited 1×
“Activation of novel PKCs, especially PKCs δ, ε, and θ, by hormones, hyperglycemia, and lipids, especially diacylglycerol, has been shown to contribute to insulin resistance (Bezy et al., 2011; Li et al., 2004; Samuel et al., 2007).”
BackgroundTremblay, F., Brûlé, S., Hee Um, S., Li, Y., Masuda, K., Roden, M., Sun, X. J., Krebs, M., Polakiewicz, R. D., Thomas, G., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706517104 · Cited by 465 · cited 1×
“, 2011) and amino acid-induced insulin resistance (Tremblay et al., 2007).”
BackgroundZierath, J. R., He, L., Gumà, A., Wahlström, E. O., Klip, A., & Wallberg-Henriksson, H. (1996) · Diabetologia · doi:10.1007/bf02658504 · Cited by 402 · cited 1×
“, 2001), decreased GLUT4 translocation (Zierath et al., 1996), and impaired insulinstimulated glucose transport, glycolytic flux, glycogen synthesis and mitochondrial ATP production (Cline et al.”
BackgroundSelf-citationRothman, D. L., Magnusson, I., Cline, G., Gerard, D., Kahn, C. R., Shulman, R. G., & Shulman, G. I. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.983 · Cited by 325 · cited 3×
“Physiological studies of T2D patients have revealed impaired glucose transport into muscle as a limiting factor causing downstream abnormalities of glucose utilization and glycogen formation (Cline et al., 1999; Rothman et al., 1995; Warram et al., 1990).”
BackgroundSelf-citationPrevis, S. F., Withers, D. J., Ren, J.-M., White, M. F., & Shulman, G. I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006490200 · Cited by 291
Signaling Specificity of Interleukin-6 Action on Glucose and Lipid Metabolism in Skeletal Muscle
Al-Khalili, L., Bouzakri, K., Glund, S., Lönnqvist, F., Koistinen, H. A., & Krook, A. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0490 · Cited by 250 · cited 1×
“Primary satellite cells were isolated and cultured as previously described (Al-Khalili et al., 2006).”
MethodSelf-citationHenry, R. R., Abrams, L., Nikoulina, S., & Ciaraldi, T. P. (1995) · Diabetes · doi:10.2337/diab.44.8.936 · Cited by 233 · cited 1×
“Likewise, primary skeletal muscle cultures from T2D patients show insulin resistance (Henry et al., 1995; Jiang et al., 2013).”
BackgroundThe Rac Activator DOCK7 Regulates Neuronal Polarity through Local Phosphorylation of Stathmin/Op18
Watabe-Uchida, M., John, K. A., Janas, J. A., Newey, S. E., & Van Aelst, L. (2006) · Neuron · doi:10.1016/j.neuron.2006.07.020 · Cited by 208 · cited 2×
“ARHGAP17 also regulates other GTPases such as RAC1, which has been implicated in insulin action (Sylow et al., 2013).”
BackgroundKowalski, G. M., & Bruce, C. R. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00165.2014 · Cited by 154
Peck, G. R., Chavez, J. A., Roach, W. G., Budnik, B. A., Lane, W. S., Karlsson, H. K. R., Zierath, J. R., & Lienhard, G. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.035568 · Cited by 95 · cited 2×
“Other proteins showing reduced phosphorylation included TBC1D1S565, S614 and MEF2CS419, which regulate GLUT4 trafficking and expression in skeletal muscle, respectively (Peck et al., 2009; Thai et al., 1998).”
BackgroundSelf-citationAltered Response of Skeletal Muscle to IL-6 in Type 2 Diabetic Patients
Jiang, L. Q., Duque-Guimaraes, D. E., Machado, U. F., Zierath, J. R., & Krook, A. (2013) · Diabetes · doi:10.2337/db11-1790 · Cited by 65 · cited 1×
“Likewise, primary skeletal muscle cultures from T2D patients show insulin resistance (Henry et al., 1995; Jiang et al., 2013).”
Background
Cited by
The aetiology and molecular landscape of insulin resistance
James, D. E., Stöckli, J., & Birnbaum, M. J. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00390-6 · Cited by 690
Applications of multi‐omics analysis in human diseases
Chen, C., Wang, J., Pan, D., Wang, X., Xu, Y., Yan, J., Wang, L., Yang, X., Yang, M., & Liu, G. (2023) · MedComm · doi:10.1002/mco2.315 · Cited by 545
Zhong, Q., Xiao, X., Qiu, Y., Xu, Z., Chen, C., Chong, B., Zhao, X., Hai, S., Li, S., An, Z., et al. (2023) · MedComm · doi:10.1002/mco2.261 · Cited by 442
The many actions of insulin in skeletal muscle, the paramount tissue determining glycemia
Sylow, L., Tokarz, V. L., Richter, E. A., & Klip, A. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.03.020 · Cited by 366
Richter, E. A., Bilan, P. J., & Klip, A. (2025) · Physiological Reviews · doi:10.1152/physrev.00033.2024 · Cited by 64
Metadata
- Authors
- Batista, T. M., Jayavelu, A. K., Wewer Albrechtsen, N. J., Iovino, S., Lebastchi, J., Pan, H., Dreyfuss, J. M., Krook, A., Zierath, J. R., Mann, M., & Kahn, C. R.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2020-11
- Volume
- 32
- Issue
- 5
- Pages
- 844-859.e5
- ISSN
- 1550-4131 (ISSN-L)
- OpenAlex
- W3082099734
- Cited by
- 107
- References
- 26
- FWCI
- 4.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.